Lunai Bioworks Inc.
LNAI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001527728
No open-market purchases or sales by Lunai Bioworks Inc. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $641.0K in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Lunai Bioworks Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 32 | 21 | −11 |
| Shares | 1.85M | 1.49M | −362.2K (−19.6%) |
| Value | $1.13M | $6.65M | +$5.53M (+490.5%) |
New holders (5)
Institutions that held Lunai Bioworks Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 24,772 | $110.7K | 0.00% |
| Jefferies Financial Group Inc. | 16,600 | $74.2K | 0.00% |
| Cubist Systematic Strategies, LLC | 10,901 | $48.7K | 0.00% |
| UBS Group AG | 6,022 | $26.9K | 0.00% |
| Simplex Trading, LLC | 74 | $0 | 0.00% |
Sold out (16)
Institutions that held Lunai Bioworks Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Houlihan Financial Resource Group, Ltd. | 201,500 | $193.0K |
| Goldman Sachs Group Inc | 118,105 | $66.9K |
| Natixis | 100,000 | $56.7K |
| Jane Street Group, LLC | 83,128 | $47.1K |
| Y-Intercept (Hong Kong) Ltd | 43,219 | $24.5K |
| Two Sigma Advisers, LP | 33,200 | $18.8K |
| Old Mission Capital LLC | 32,262 | $18.3K |
| Two Sigma Investments, LP | 31,023 | $17.6K |
| Deutsche Bank AG | 29,648 | $16.8K |
| Virtu Financial LLC | 11,029 | $6.00K |
| JPMorgan Chase & Co | 7,126 | $4.04K |
| Rhumbline Advisers | 5,517 | $3.13K |
| FMR LLC | 828 | $469 |
| New York State Common Retirement Fund | 200 | $113 |
| Group One Trading, L.P. | 1 | $1 |
| Royal Bank of Canada | 709 | $0 |